ReviewTherapeutic advances in medical oncology2023

What is the optimal duration, dose and frequency for anti-PD1 therapy of non-small cell lung cancer?

Chii Yang Kuah et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.